Breast Carcinoma: Clinical Trials

30 trials for Breast Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 5 recruiting, 5 terminated, 5 withdrawn. 30 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 130Completed 8, Recruiting 5, Terminated 5, Withdrawn 5, Active not recruiting 4, Unknown 2, Suspended 1
Phase 24Completed 2, Recruiting 1, Withdrawn 1

Follow Breast Carcinoma: new trials by email Literature Review of Breast Carcinoma trials Research Report on Breast Carcinoma

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Radiation: Accelerated Partial Breast Irradiation (APBI) - Early-stage Breast Cancer, Breast Carcinoma
Phase 1SuspendedRutgers, The State University of New Jersey982025-09-022025-11-14
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma
Phase 1Active not recruitingJonsson Comprehensive Cancer Center302025-08-012026-10-20
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
ATV-1601, ATV-1601 + Fulvestrant - Advanced Solid Tumors, Breast Cancer
Phase 1Active not recruitingAtavistik Bio, Inc1342025-07-292026-08-07
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
Biopsy, Biospecimen Collection, Bone Scan - Breast Carcinoma, Colorectal Carcinoma
Phase 1RecruitingCity of Hope Medical Center242025-05-272026-11-03
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamid, Fludarabine - Breast Cancer, Breast Carcinoma
Phase 1 / Phase 2RecruitingEssen Biotech852024-08-222024-11-12
FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer
Administration of CC-3 - Colorectal Cancer, Breast Carcinoma
Phase 1RecruitingGerman Cancer Research Center892024-01-122025-05-21
Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain
Phase 1WithdrawnNorthwestern University2023-12-312024-04-01
Vaccine Response With NT-I7
Recombinant human IL-7-hyFc (NT-I7), Vaccine sequence 1, Vaccine sequence 2 - Breast Carcinoma, Colorectal Adenocarcinoma
Phase 1WithdrawnNational Cancer Institute (NCI)2023-05-302023-11-02
Implantable Microdevice for TNBC - Pilot Study
Implantable Microdevice (IMD) - Triple Negative Breast Cancer, Breast Cancer Stage II
Phase 1WithdrawnDana-Farber Cancer Institute2023-05-012023-05-18
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC
NUV-422, Fulvestrant - Advanced Breast Cancer, Metastatic Breast Cancer
Phase 1 / Phase 2WithdrawnNuvation Bio Inc.2022-09-012023-07-11
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer
Phase 1TerminatedNuvation Bio Inc.822022-03-292025-11-06
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
NUV-422 - Glioma, Glioma, Malignant
Phase 1TerminatedNuvation Bio Inc.742020-12-082023-07-14
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
Contrast-Enhanced Ultrasound, Perflutren Lipid Microspheres, Sulfur Hexafluoride Lipid Microspheres - Breast Carcinoma
Phase 1RecruitingUniversity of Southern California1002020-11-052026-02-02
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Biospecimen Collection, Genetic Counseling, Genetic Testing - Breast Carcinoma, Digestive System Neoplasm
Phase 1CompletedMayo Clinic2302020-06-292023-07-24
Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus
rVV-740CTA - Breast Carcinoma
Phase 1WithdrawnUniversity Hospital, Basel, Switzerland2020-03-012020-02-07
Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer
Fingolimod, Fingolimod Hydrochloride, Questionnaire Administration - Breast Carcinoma
Phase 1CompletedMayo Clinic22019-12-122023-07-21
A Safety Study of SGN-CD47M in Patients With Solid Tumors
SGN-CD47M - Soft Tissue Sarcoma, Colorectal Cancer
Phase 1TerminatedSeagen Inc.162019-07-172020-09-17
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer
Gallium Ga 68-labeled GRPR Antagonist BAY86-7548, Magnetic Resonance Imaging, Positron Emission Tomography - Breast Carcinoma, Estrogen Receptor Positive
Phase 1 / Phase 2CompletedAndrei Iagaru52019-03-192023-12-13
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18 Fluorthanatrace - Breast Carcinoma, Fallopian Tube Carcinoma
Phase 1RecruitingM.D. Anderson Cancer Center3002018-12-182026-10-06
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
XmAb20717 - Melanoma, Breast Carcinoma
Phase 1CompletedXencor, Inc.1502018-07-102022-12-01

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Breast Neoplasms (30)  ·  Ovarian Neoplasms (9)  ·  Colorectal Neoplasms (6)  ·  Prostatic Neoplasms (6)  ·  Triple Negative Breast Neoplasms (6)  ·  Melanoma (5)  ·  Sarcoma (5)  ·  Endometrial Neoplasms (4)  ·  Head and Neck Neoplasms (4)  ·  Pancreatic Neoplasms (4)  ·  Stomach Neoplasms (4)  ·  Uterine Cervical Neoplasms (4)  ·  Anus Neoplasms (3)  ·  Brain Neoplasms (3)  ·  Carcinoma, Hepatocellular (3)

Broader conditions

Skin Diseases (30)  ·  Skin and Connective Tissue Diseases (30)  ·  Breast Diseases (29)  ·  Neoplasms by Site (29)  ·  Neoplasms (28)  ·  Urogenital Diseases (14)  ·  Digestive System Diseases (12)  ·  Female Urogenital Diseases (12)  ·  Female Urogenital Diseases and Pregnancy Complications (12)  ·  Genital Diseases (12)  ·  Urogenital Neoplasms (12)  ·  Digestive System Neoplasms (11)  ·  Male Urogenital Diseases (11)  ·  Neoplasms by Histologic Type (11)  ·  Endocrine Gland Neoplasms (10)

Interventions

Magnetic Resonance Spectroscopy (5)  ·  Fluorodeoxyglucose F18 (2)  ·  Fulvestrant (2)  ·  Interleukin-2 (2)  ·  Radiation (2)  ·  Specimen Handling (2)  ·  veliparib (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Adjuvants, Immunologic (1)  ·  Albumin-Bound Paclitaxel (1)  ·  BAY 86-7548 (1)  ·  Biopsy (1)  ·  Carboplatin (1)  ·  Cyclophosphamide (1)  ·  FAPI-46 (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Nuvation Bio Inc. (3)  ·  Mayo Clinic (2)  ·  Andrei Iagaru (1)  ·  Atavistik Bio, Inc (1)  ·  City of Hope Medical Center (1)  ·  Columbia University (1)  ·  Dana-Farber Cancer Institute (1)  ·  Dawn L. Hershman (1)  ·  Essen Biotech (1)  ·  German Cancer Research Center (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mannkind Corporation (1)  ·  Northwestern University (1)

Countries

United States (24)  ·  China (3)  ·  Australia (1)  ·  France (1)  ·  Germany (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

Ana Garrido-Castro, MD (1)  ·  Andrei Iagaru (1)  ·  Bino A Varghese, PhD (1)  ·  Charles L Loprinzi (1)  ·  Dawn Hershman, MD, MS (1)  ·  Hussein A Tawbi (1)  ·  Jeffrey Y Wong (1)  ·  Jeremie Calais (1)  ·  Kevin Kalinsky, MD, MS (1)  ·  Lilie L Lin (1)  ·  Michael Schmitt, MD, PhD (1)  ·  Mustafa A Hyder, M.D. (1)  ·  Niloy J Samadder (1)  ·  Roger Stupp, MD (1)

Results publications

PMID 16818691, PMID 18077538, PMID 34519839, PMID 34627593, PMID 36585452, PMID 38967722, PMID 39208372, PMID 40881578, PMID 42094867

NIH funding

P30CA047904 (2), U01CA062505 (2), U01CA099168 (2), U01CA168426 (2), UM1CA186690 (2), UM1CA186716 (2), UM1CA186717 (2), N01CM00100 (1), P30CA014089 (1), P30CA015083 (1), P30CA033572 (1), P30CA060553 (1), R01CA249329 (1), R01CA283603 (1), U01CA062490 (1)